JAK2 and non-small cell lung carcinoma: In addition, the overexpression of miR-153 was found to inhibit the proliferation and promote the apoptosis of A549 cells by suppressing the JAK2/STAT3 signaling pathway, suggesting that targeting miR-153 and the JAK/STAT pathway may have therapeutic potential for NSCLC treatment.